Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer

View source ↗

Summary

This document is a clinical trial update evaluating the safety of TALZENNA (talazoparib) for treating breast cancer. The study is sponsored by Pfizer and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Talzenna (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING